Literature DB >> 24900608

Chemical Probe Identification Platform for Orphan GPCRs Using Focused Compound Screening: GPR39 as a Case Example.

Markus Boehm1, David Hepworth1, Paula M Loria2, Lisa D Norquay1, Kevin J Filipski1, Janice E Chin1, Kimberly O Cameron1, Martin Brenner1, Peter Bonnette1, Shawn Cabral1, Edward Conn1, David C Ebner1, Denise Gautreau1, John Hadcock1, Esther C Y Lee1, Alan M Mathiowetz1, Michelle Morin1, Lucy Rogers2, Aaron Smith1, Maria VanVolkenburg1, Philip A Carpino1.   

Abstract

Orphan G protein-coupled receptors (oGPCRs) are a class of integral membrane proteins for which endogenous ligands or transmitters have not yet been discovered. Transgenic animal technologies have uncovered potential roles for many of these oGPCRs, providing new targets for the treatment of various diseases. Understanding signaling pathways of oGPCRs and validating these receptors as potential drug targets requires the identification of chemical probe compounds to be used in place of endogenous ligands to interrogate these receptors. A novel chemical probe identification platform was created in which GPCR-focused libraries were screened against sets of oGPCR targets, with a goal of discovering fit-for-purpose chemical probes for the more druggable members of the set. Application of the platform to a set of oGPCRs resulted in the discovery of the first reported small molecule agonists for GPR39, a receptor implicated in the regulation of insulin secretion and preservation of beta cells in the pancreas. Compound 1 stimulated intracellular calcium mobilization in recombinant and native cells in a GPR39-specific manner but did not potentiate glucose-stimulated insulin secretion in human islet preparations.

Entities:  

Keywords:  GPCR-focused chemical library; GPR39; Orphan GPCRs; chemical probe identification platform

Year:  2013        PMID: 24900608      PMCID: PMC4027148          DOI: 10.1021/ml400275z

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  23 in total

Review 1.  The design of screening libraries targeted at G-protein coupled receptors.

Authors:  Roger Crossley
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

2.  Using extended-connectivity fingerprints with Laplacian-modified Bayesian analysis in high-throughput screening follow-up.

Authors:  David Rogers; Robert D Brown; Mathew Hahn
Journal:  J Biomol Screen       Date:  2005-09-16

3.  Comparison of shape-matching and docking as virtual screening tools.

Authors:  Paul C D Hawkins; A Geoffrey Skillman; Anthony Nicholls
Journal:  J Med Chem       Date:  2007-01-11       Impact factor: 7.446

4.  Discovery of the first nonpeptidic, small-molecule, highly selective somatostatin receptor subtype 5 antagonists: a chemogenomics approach.

Authors:  Rainer E Martin; Luke G Green; Wolfgang Guba; Nicole Kratochwil; Andreas Christ
Journal:  J Med Chem       Date:  2007-11-19       Impact factor: 7.446

5.  Disruption of G protein-coupled receptor 39 impairs insulin secretion in vivo.

Authors:  Frédéric Tremblay; Ann-Marie T Richard; Sarah Will; Jameel Syed; Nancy Stedman; Mylène Perreault; Ruth E Gimeno
Journal:  Endocrinology       Date:  2009-02-12       Impact factor: 4.736

Review 6.  G protein-coupled receptor deorphanizations.

Authors:  Olivier Civelli; Rainer K Reinscheid; Yan Zhang; Zhiwei Wang; Robert Fredriksson; Helgi B Schiöth
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-09-28       Impact factor: 13.820

7.  Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors.

Authors:  K K McKee; C P Tan; O C Palyha; J Liu; S D Feighner; D L Hreniuk; R G Smith; A D Howard; L H Van der Ploeg
Journal:  Genomics       Date:  1997-12-15       Impact factor: 5.736

Review 8.  Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)?

Authors:  G Gourcerol; D H St-Pierre; Y Taché
Journal:  Regul Pept       Date:  2007-01-12

9.  GPR39, a receptor of the ghrelin receptor family, plays a role in the regulation of glucose homeostasis in a mouse model of early onset diet-induced obesity.

Authors:  P J Verhulst; A Lintermans; S Janssen; D Loeckx; U Himmelreich; J Buyse; J Tack; I Depoortere
Journal:  J Neuroendocrinol       Date:  2011-06       Impact factor: 3.627

Review 10.  Fine-tuning of GPCR activity by receptor-interacting proteins.

Authors:  Stefanie L Ritter; Randy A Hall
Journal:  Nat Rev Mol Cell Biol       Date:  2009-12       Impact factor: 94.444

View more
  8 in total

1.  Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists.

Authors:  Stefan Peukert; Richard Hughes; Jill Nunez; Guo He; Zhao Yan; Rishi Jain; Luis Llamas; Sarah Luchansky; Adam Carlson; Guiqing Liang; Vidya Kunjathoor; Mike Pietropaolo; Jeffrey Shapiro; Anja Castellana; Xiaoping Wu; Avirup Bose
Journal:  ACS Med Chem Lett       Date:  2014-08-04       Impact factor: 4.345

2.  Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc.

Authors:  Seiji Sato; Xi-Ping Huang; Wesley K Kroeze; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2016-10-17       Impact factor: 4.436

3.  Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39.

Authors:  Frederic Bassilana; Adam Carlson; Jennifer A DaSilva; Bianka Grosshans; Solange Vidal; Valerie Beck; Barbara Wilmeringwetter; Luis A Llamas; Todd B Showalter; Pascal Rigollier; Aaron Bourret; Arun Ramamurthy; Xu Wu; Fred Harbinski; Samantha Plonsky; Lac Lee; Heinz Ruffner; Paola Grandi; Markus Schirle; Jeremy Jenkins; Andreas W Sailer; Tewis Bouwmeester; Jeffrey A Porter; Vic Myer; Peter M Finan; John A Tallarico; Joseph F Kelleher; Klaus Seuwen; Rishi K Jain; Sarah J Luchansky
Journal:  Nat Chem Biol       Date:  2014-03-16       Impact factor: 15.040

Review 4.  Neuro-psychopharmacological perspective of Orphan receptors of Rhodopsin (class A) family of G protein-coupled receptors.

Authors:  Muhammad Zahid Khan; Ling He
Journal:  Psychopharmacology (Berl)       Date:  2017-03-13       Impact factor: 4.530

5.  What can we learn from molecular dynamics simulations for GPCR drug design?

Authors:  Christofer S Tautermann; Daniel Seeliger; Jan M Kriegl
Journal:  Comput Struct Biotechnol J       Date:  2014-12-10       Impact factor: 7.271

6.  Novel Zn2+ Modulated GPR39 Receptor Agonists Do Not Drive Acute Insulin Secretion in Rodents.

Authors:  Ola Fjellström; Niklas Larsson; Shin-Ichiro Yasuda; Takuma Tsuchida; Takahiro Oguma; Anna Marley; Charlotte Wennberg-Huldt; Daniel Hovdal; Hajime Fukuda; Yukimi Yoneyama; Kazuyo Sasaki; Anders Johansson; Sara Lundqvist; Johan Brengdahl; Richard J Isaacs; Daniel Brown; Stefan Geschwindner; Lambertus Benthem; Claire Priest; Andrew Turnbull
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

Review 7.  The Zinc-Sensing Receptor GPR39 in Physiology and as a Pharmacological Target.

Authors:  Anna Laitakari; Lingzhi Liu; Thomas M Frimurer; Birgitte Holst
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 8.  Pharmacology and physiology of gastrointestinal enteroendocrine cells.

Authors:  O J Mace; B Tehan; F Marshall
Journal:  Pharmacol Res Perspect       Date:  2015-07-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.